Video: Dr. Alyson Kelvin's COVID-19 research at VIDO
Dr. Alyson Kelvin is a visiting scientist at VIDO researching COVID-19 since February 2020. Find out how the containment facilities and research collaborations are supporting efforts to develop solutions for the pandemic.
Video: Dr. Jason Kindrachuk's COVID-19 research at VIDO
Dr. Jason Kindrachuk is a visiting scientist at VIDO to advance research against COVID-19. In this video, he explains his expertise in emerging viruses, and why the capabilities of VIDO and its research teams help drive Canada’s pandemic response.
Video: Emerging coronavirus research at VIDO
Dr. Darryl Falzarano and his team are focused on emerging viruses. In this video they describe the development of innovative solutions and the importance of understanding emerging infectious diseases so we are better prepared for future threats.
VIDO-InterVac on track to become ‘Canada’s centre for pandemic research’
A major takeaway from the COVID-19 pandemic is that emerging diseases require rapid responses and Canada needs to be better prepared to respond to the next one.
CLC Public Meeting: COVID-19 Vaccine Development
Watch the recording of the VIDO-InterVac Community Liaison Committee Public Meeting.
VIDO-InterVac COVID-19 vaccine to start toxicology studies
Our work to develop and advance a COVID-19 vaccine candidate has progressed rapidly throughout the summer.
Making a difference: USask research centres help to combat COVID-19 pandemic
Several University of Saskatchewan research centres are supporting the international effort to fight COVID-19 with some of the most advanced research tools Canada has to offer.
Uniquely USask: VIDO-InterVac a world-class research facility
It is one of the largest and most advanced infectious disease research facilities in the world, with unique features that attract scientists from across the country and around the globe.
Video: Developing a vaccine for COVID-19
Research technicians Jocelyne Lew and Shelby Landreth discuss how they are helping to develop a vaccine and test antivirals for COVID-19. They are members of a larger team working to advance solutions for this new virus (SARS-CoV-2).
VIDO-InterVac making progress on vaccine
There are some promising early signs as researchers at the VIDO-InterVac develop a vaccine for COVID-19.
VIDO-InterVac team tackles coronavirus: Researchers developing prototype vaccines at USask
As the world deals with the new pandemic, the novel coronavirus has become the No.1 priority for researchers VIDO-InterVac.
Video: Novel Coronavirus Research at VIDO-InterVac
Dr. Volker Gerdts, director and CEO, discusses ongoing efforts at VIDO-InterVac to develop a vaccine for the novel coronavirus causing COVID-19.